A detailed history of M. Kulyk & Associates, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, M. Kulyk & Associates, LLC holds 64,872 shares of MRK stock, worth $6.43 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares
64,872
Previous 62,776 3.34%
Holding current value
$6.43 Million
Previous $7.77 Million 5.21%
% of portfolio
1.5%
Previous 1.83%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$111.15 - $128.97 $232,970 - $270,321
2,096 Added 3.34%
64,872 $7.37 Million
Q2 2024

Aug 05, 2024

BUY
$123.8 - $132.96 $48,777 - $52,386
394 Added 0.63%
62,776 $7.77 Million
Q1 2024

May 09, 2024

BUY
$113.24 - $131.95 $173,710 - $202,411
1,534 Added 2.52%
62,382 $8.23 Million
Q4 2023

Feb 08, 2024

BUY
$100.18 - $109.02 $372,669 - $405,554
3,720 Added 6.51%
60,848 $6.63 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $934,786 - $1.04 Million
9,080 Added 18.9%
57,128 $5.88 Million
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $178,772 - $194,853
-1,646 Reduced 3.31%
48,048 $5.54 Million
Q1 2023

May 08, 2023

BUY
$102.94 - $114.86 $227,600 - $253,955
2,211 Added 4.66%
49,694 $5.29 Million
Q4 2022

Feb 08, 2023

BUY
$87.44 - $112.11 $80,882 - $103,701
925 Added 1.99%
47,483 $5.27 Million
Q3 2022

Nov 07, 2022

BUY
$84.53 - $94.96 $3.94 Million - $4.42 Million
46,558 New
46,558 $4.01 Million
Q2 2022

Aug 05, 2022

SELL
$83.49 - $94.64 $258,818 - $293,384
-3,100 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$73.51 - $82.4 $102,178 - $114,536
-1,390 Reduced 30.96%
3,100 $254,000
Q4 2021

Jan 20, 2022

BUY
$72.28 - $90.54 $101,192 - $126,756
1,400 Added 45.31%
4,490 $344,000
Q3 2021

Oct 21, 2021

BUY
$71.68 - $78.83 $25,733 - $28,299
359 Added 13.15%
3,090 $232,000
Q1 2021

Apr 29, 2021

SELL
$68.86 - $81.11 $6,748 - $7,948
-98 Reduced 3.46%
2,731 $211,000
Q4 2020

Feb 02, 2021

BUY
$71.77 - $79.65 $203,037 - $225,329
2,829 New
2,829 $231,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track M. Kulyk & Associates, LLC Portfolio

Follow M. Kulyk & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kulyk & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M. Kulyk & Associates, LLC with notifications on news.